Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.</p>

Research Examines Self-administered DMPA